HDAC5 modulates SATB1 transcriptional activity to promote lung adenocarcinoma

[1]  Xin Jin,et al.  HDAC5 modulates PD-L1 expression and cancer immunity via p65 deacetylation in pancreatic cancer , 2022, Theranostics.

[2]  Li Sun,et al.  Lactate Modulates Cellular Metabolism Through Histone Lactylation-Mediated Gene Expression in Non-Small Cell Lung Cancer , 2021, Frontiers in Oncology.

[3]  A. Piotrowska,et al.  SATB1 protein is associated with the epithelial-mesenchymal transition process in non-small cell lung cancers , 2021, Oncology reports.

[4]  M. Sudol,et al.  YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer. , 2020, Cancer letters.

[5]  M. Sudol,et al.  YAP/TAZ and EZH2 synergize to impair tumor suppressor activity of TGFBR2 in non-small cell lung cancer , 2020, bioRxiv.

[6]  R. DePinho,et al.  Tumor microenvironment remodeling enables bypass of oncogenic KRAS dependency in pancreatic cancer. , 2020, Cancer discovery.

[7]  Chun Zhou,et al.  Acetylation of XPF by TIP60 facilitates XPF-ERCC1 complex assembly and activation , 2020, Nature Communications.

[8]  R. Pacchiana,et al.  Regulation of succinate dehydrogenase and role of succinate in cancer. , 2020, Seminars in cell & developmental biology.

[9]  T. K. Ghosh,et al.  HDAC4 and 5 repression of TBX5 is relieved by protein kinase D1 , 2019, Scientific Reports.

[10]  Yue Xue,et al.  HDAC5-mediated deacetylation and nuclear localisation of SOX9 is critical for tamoxifen resistance in breast cancer , 2019, British Journal of Cancer.

[11]  Shun-Fa Yang,et al.  TIMP-3 as a therapeutic target for cancer , 2019, Therapeutic advances in medical oncology.

[12]  G. Tarján,et al.  Succinate Dehydrogenase Complex: An Updated Review. , 2018, Archives of pathology & laboratory medicine.

[13]  Sanjeev Das,et al.  Cyclin F-Dependent Degradation of RBPJ Inhibits IDH1R132H-Mediated Tumorigenesis. , 2018, Cancer research.

[14]  Y. Zhuang,et al.  Lactate dehydrogenase is correlated with clinical stage and grade and is downregulated by si‑SAΤB1 in ovarian cancer. , 2018, Oncology reports.

[15]  D. Tenen,et al.  TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter , 2017, PLoS pathogens.

[16]  Yu Bai,et al.  Hypermethylation of miRNA-589 promoter leads to upregulation of HDAC5 which promotes malignancy in non-small cell lung cancer. , 2017, International journal of oncology.

[17]  Xiaoli Zhang,et al.  Tip60: Main Functions and Its Inhibitors. , 2017, Mini reviews in medicinal chemistry.

[18]  Bo Mu,et al.  SATB1 plays an oncogenic role in esophageal cancer by up-regulation of FN1 and PDGFRB , 2017, Oncotarget.

[19]  J. Sweatt,et al.  Extra-coding RNAs regulate neuronal DNA methylation dynamics , 2016, Nature Communications.

[20]  J. Fine,et al.  Functional Interaction of Histone Deacetylase 5 (HDAC5) and Lysine-specific Demethylase 1 (LSD1) Promotes Breast Cancer Progression , 2016, Oncogene.

[21]  S. Galande,et al.  Wnt/β-catenin signaling regulated SATB1 promotes colorectal cancer tumorigenesis and progression , 2016, Oncogene.

[22]  S. Das,et al.  Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73 , 2016, Oncogene.

[23]  P. Devilee,et al.  Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors , 2015, Oncotarget.

[24]  Ian A Blair,et al.  Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation. , 2014, Cell metabolism.

[25]  Sanjeev Das,et al.  HDAC5, a key component in temporal regulation of p53-mediated transactivation in response to genotoxic stress. , 2013, Molecular cell.

[26]  C. Der,et al.  CRL4A-FBXW5–mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth , 2013, Proceedings of the National Academy of Sciences.

[27]  Laurence Amar,et al.  SDH mutations establish a hypermethylator phenotype in paraganglioma. , 2013, Cancer cell.

[28]  M. Novatchkova,et al.  SATB1 collaborates with loss of p16 in cellular transformation , 2013, Oncogene.

[29]  D. Tian,et al.  Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[30]  Hui Yang,et al.  Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors. , 2012, Genes & development.

[31]  De-Pei Liu,et al.  SIRT1 deacetylates SATB1 to facilitate MARHS2-MARε interaction and promote ε-globin expression , 2012, Nucleic acids research.

[32]  Ravindra Kamath,et al.  Tip60-mediated acetylation activates transcription independent apoptotic activity of Abl , 2011, Molecular Cancer.

[33]  X. Hu,et al.  Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer. , 2008, Lung cancer.

[34]  C. Piantadosi,et al.  Transcriptional Regulation of SDHa Flavoprotein by Nuclear Respiratory Factor-1 Prevents Pseudo-hypoxia in Aerobic Cardiac Cells* , 2008, Journal of Biological Chemistry.

[35]  J. Russo,et al.  SATB1 reprogrammes gene expression to promote breast tumour growth and metastasis , 2008, Nature.

[36]  S. Galande,et al.  The third dimension of gene regulation: organization of dynamic chromatin loopscape by SATB1. , 2007, Current opinion in genetics & development.

[37]  John Lough,et al.  Tip60 is a haplo-insufficient tumour suppressor required for an oncogene-induced DNA damage response , 2007, Nature.

[38]  H. Ryoo,et al.  Bone Morphogenetic Protein-2 Stimulates Runx2 Acetylation* , 2006, Journal of Biological Chemistry.

[39]  Sanjeev Galande,et al.  Phosphorylation of SATB1, a global gene regulator, acts as a molecular switch regulating its transcriptional activity in vivo. , 2006, Molecular cell.

[40]  Xiaofeng Jiang,et al.  A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Jun-ichi Sawada,et al.  The Ubiquitin Ligase Activity in the DDB2 and CSA Complexes Is Differentially Regulated by the COP9 Signalosome in Response to DNA Damage , 2003, Cell.

[42]  T. Kohwi-Shigematsu,et al.  SATB1 targets chromatin remodelling to regulate genes over long distances , 2002, Nature.

[43]  L. Linares,et al.  Tip60 is targeted to proteasome‐mediated degradation by Mdm2 and accumulates after UV irradiation , 2002, The EMBO journal.

[44]  J. Minna,et al.  Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. , 2001, Journal of the National Cancer Institute.

[45]  C. Croce,et al.  Loss of FHIT function in lung cancer and preinvasive bronchial lesions. , 1998, Cancer research.

[46]  J. Herman,et al.  5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.

[47]  K. Nakagomi,et al.  A novel DNA-binding motif in the nuclear matrix attachment DNA-binding protein SATB1 , 1994, Molecular and cellular biology.

[48]  D. Feng,et al.  Correlation between SATB1 and Bcl-2 expression in human glioblastoma multiforme. , 2013, Molecular medicine reports.

[49]  Xiao Hua,et al.  Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer , 2008 .

[50]  K. Kinzler,et al.  A simplified system for generating recombinant adenoviruses. , 1998, Proceedings of the National Academy of Sciences of the United States of America.